Literature DB >> 35659283

A genetic correlation scan identifies blood proteins associated with bone mineral density.

Jiawen Xu1, Shaoyun Zhang1, Haibo Si1, Yi Zeng1, Yuangang Wu1, Yuan Liu1, Mingyang Li1, Limin Wu1, Bin Shen2.   

Abstract

BACKGROUND: Osteoporosis is a common metabolic bone disease that is characterized by low bone mass. However, limited efforts have been made to explore the functional relevance of the blood proteome to bone mineral density across different life stages.
METHODS: Using genome-wide association study summary data of the blood proteome and two independent studies of bone mineral density, we conducted a genetic correlation scan of bone mineral density and the blood proteome. Linkage disequilibrium score regression analysis was conducted to assess genetic correlations between each of the 3283 plasma proteins and bone mineral density.
RESULTS: Linkage disequilibrium score regression identified 18 plasma proteins showing genetic correlation signals with bone mineral density in the TB-BMD cohort, such as MYOM2 (coefficient = 0.3755, P value = 0.0328) among subjects aged 0 ~ 15, POSTN (coefficient = - 0.5694, P value = 0.0192) among subjects aged 30 ~ 45 and PARK7 (coefficient = - 0.3613, P value = 0.0052) among subjects aged over 60.
CONCLUSIONS: Our results identified multiple plasma proteins associated with bone mineral density and provided novel clues for revealing the functional relevance of plasma proteins to bone mineral density.
© 2022. The Author(s).

Entities:  

Keywords:  Blood proteome; Bone mineral density; Genome-wide association study; Human plasma protein; Linkage disequilibrium score regression; Osteoporosis

Mesh:

Substances:

Year:  2022        PMID: 35659283      PMCID: PMC9164489          DOI: 10.1186/s12891-022-05453-z

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.562


  48 in total

Review 1.  Interaction of genetic and environmental influences on peak bone density.

Authors:  P J Kelly; J A Eisman; P N Sambrook
Journal:  Osteoporos Int       Date:  1990-10       Impact factor: 4.507

2.  The effects of direct factor Xa inhibitor (Rivaroxaban) on the human osteoblastic cell line SaOS2.

Authors:  Roy Gigi; Moshe Salai; Oleg Dolkart; Ofir Chechik; Sarah Katzburg; Naftali Stern; Dalia Somjen
Journal:  Connect Tissue Res       Date:  2012-08-23       Impact factor: 3.417

3.  Influence of heredity and environment on peak bone density: a parent-offspring study.

Authors:  Selma Cvijetic; Irena Colic Baric; Zvonimir Satalic
Journal:  J Clin Densitom       Date:  2010-06-12       Impact factor: 2.617

Review 4.  Periostin action in bone.

Authors:  Nicolas Bonnet; Patrick Garnero; Serge Ferrari
Journal:  Mol Cell Endocrinol       Date:  2015-12-22       Impact factor: 4.102

5.  Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.

Authors:  H Kim; K H Baek; S-Y Lee; S H Ahn; S H Lee; J-M Koh; Y Rhee; C H Kim; D-Y Kim; M-I Kang; B-J Kim; Y-K Min
Journal:  Osteoporos Int       Date:  2016-11-19       Impact factor: 4.507

Review 6.  Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer.

Authors:  April A N Rose; Marco Biondini; Rafael Curiel; Peter M Siegel
Journal:  Pharmacol Ther       Date:  2017-05-22       Impact factor: 12.310

7.  Osteoporosis and osteoblasts cocultured with adipocytes inhibit osteoblast differentiation by downregulating histone acetylation.

Authors:  Rodrigo P F Abuna; Luciana O Almeida; Alann T P Souza; Roger R Fernandes; Thales F V Sverzut; Adalberto L Rosa; Marcio M Beloti
Journal:  J Cell Physiol       Date:  2020-10-30       Impact factor: 6.384

8.  Osteoactivin induces transdifferentiation of C2C12 myoblasts into osteoblasts.

Authors:  Gregory R Sondag; Sibel Salihoglu; Suzanne L Lababidi; Douglas C Crowder; Fouad M Moussa; Samir M Abdelmagid; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2014-07       Impact factor: 6.384

Review 9.  Osteoporosis.

Authors:  Kristine E Ensrud; Carolyn J Crandall
Journal:  Ann Intern Med       Date:  2017-08-01       Impact factor: 25.391

10.  SCOPE 2021: a new scorecard for osteoporosis in Europe.

Authors:  John A Kanis; Nicholas Norton; Nicholas C Harvey; Trolle Jacobson; Helena Johansson; Mattias Lorentzon; Eugene V McCloskey; Carl Willers; Fredrik Borgström
Journal:  Arch Osteoporos       Date:  2021-06-02       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.